Your Trusted Partner in Diversion Control, DEA Compliance, and Regulatory Strategy

Brinks DEA Consulting is a specialized firm offering expert guidance in controlled substance diversion prevention, DEA compliance, and regulatory strategy. Founded by Scott A. Brinks—a nationally recognized authority with over two decades of federal law enforcement and regulatory experience—the firm serves healthcare systems, law enforcement agencies, pharmaceutical companies, and regulatory bodies.

We provide tailored solutions to help organizations strengthen their controlled substance programs, reduce diversion risk, and maintain full compliance with federal and state regulations. Our services include:

DEA compliance consulting
Diversion prevention program development
Investigative support
Training and education
Public speaking and strategic advisory
Why Choose Us?

Led by Experience: Scott Brinks is a former DEA Diversion Investigator and current Administrator of Diversion Prevention & Engagement at a major hospital system.

Proven Impact: From leading national investigations to shaping DEA regulations, our work has influenced public health policy and enforcement practices.

Award-Winning Leadership: Honored with the United States Attorneys Award for Distinguished Service and the NHCAA Investigation of the Year.
Comprehensive Services: Grounded in real-world expertise and designed to meet the evolving needs of healthcare and regulatory environments.
At Brinks DEA Consulting, we build coalitions, drive change, and deliver results.

Brinks DEA Consulting

Org chart

Teams

Offices